HIL profiled in Start-Up Magazine

HIL’s Shmuel Eisenmann and Sagi Brink-Danan spoke with Elsevier’s Bob Kronemyer about the promise of proton beam cancer radiotherapy, its current limitations, and the company’s vision to bring it to every eligible patient.

Elsevier Business Intelligence’s Start-Up features in-depth profiles of leading-edge companies and technologies, including the most important new trends in the biopharma, medtech and diagnostics industries.